Clinical Trials Logo

Thoracoabdominal Aneurysm clinical trials

View clinical trials related to Thoracoabdominal Aneurysm.

Filter by:
  • None
  • Page 1

NCT ID: NCT05531084 Not yet recruiting - Aortic Aneurysm Clinical Trials

Safety and Effectiveness of Surgeon-Modified Stent Grafts forTreatment of Complex Aortic Aneurysms

Assets
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The primary objective of the present study is to evaluate the safety, effectiveness, and clinical outcomes of surgeon-modified fenestrated stent grafts used to treat patients with failed previous infrarenal repairs (failed EVAR) and complex aortic aneurysms (thoracoabdominal, juxtarenal, pararenal, and paravisceral aneurysms).

NCT ID: NCT05442489 Available - Clinical trials for Thoracoabdominal Aneurysm

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE)

TAMBE
Start date: n/a
Phase:
Study type: Expanded Access

Expanded access tothe GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis is safe and effective in the treatment of thoracoabdominal and pararenal aneurysms.

NCT ID: NCT04689139 Completed - Aortic Aneurysm Clinical Trials

Biomarkers in Thoracic Aorta Surgery

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Biomarkers can play a vital role in prognosing the perioperative complications in thoracic aorta surgery. The goal of a study is to determine the correlation between intraoperative level of certain biomarkers and total amount of peroperative complications.

NCT ID: NCT03342755 Completed - Clinical trials for Thoracoabdominal Aneurysm

Evaluation of STaged Endovascular Aneurysm Repair in the Management of Thoracoabdominal Pathology by Means of Branched and Fenestrated Devices.(STEAR)

STEAR
Start date: November 21, 2017
Phase:
Study type: Observational

The study aims to analyzing the impact of the staged endovascular treatment (divided into two or more distinct procedures) of thoracoabdominal aneurysmatic pathology on short and medium term, technical and clinical outcomes and on the possible benefits or complications associated with this approach.

NCT ID: NCT03295682 Active, not recruiting - Clinical trials for Thoracoabdominal Aneurysm

Registry in Patients With Thoracoabdominal Aneurysms

CONNECT
Start date: September 11, 2017
Phase:
Study type: Observational [Patient Registry]

In this study patients will be observed, who receive a multi-branch stent graft tailored to the patients anatomy for the endovascular treatment of a thoracoabdominal aortic aneurysm Crawford type I, II, III, IV or V. The objective of this study is to evaluate clinical and technical success as well as safety and feasibility of the multi-branch stent graft Systems used in endovascular treatment of thoracoabdominal aortic aneurysms that cannot be treated with commercially available devices. Primary endpoint of this study is the rate of patients with stable or decreasing aneurysm size at 12 months follow-up.

NCT ID: NCT03111459 Recruiting - Clinical trials for Thoracoabdominal Aneurysm

Repair of Thoracoabdominal Aortic Aneurysms

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

The primary objective of the clinical investigation is to assess the use of the Medtronic Valiant Thoracoabdominal Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.

NCT ID: NCT03074487 Recruiting - Postoperative Clinical Trials

Evaluating Monitoring Techniques for Postoperative Spinal Cord Ischemia

SINATRA
Start date: January 2017
Phase:
Study type: Observational

During open surgery of a thoraco-abdominal aortic aneurysma (TAAA), diminished blood flow to the myelum can result in hypoxia, compromising proper function of the spinal cord. Intraoperatively, motor evoked potentials (MEP) are elicited to measure the functional integrity of the spinal cord. MEPs have proven to be a reliable marker of spinal cord ischemia. Moreover, these potentials react within minutes, which facilitates interventions to restore the blood flow. Monitoring intraoperatively with this ancillary test has reduced the rate of paraparesis to < 5%. Unfortunately, in the early postoperative period, spinal cord vulnerability is high. Therefore, some patients develop paraparesis, not during the surgical procedure, but after the surgical procedure. Postoperatively, suboptimal blood flow may lead to critical loss of function. This inadequate perfusion results in "delayed paraparesis". In the postoperative patient, it is not possible to measure MEPs when sedation is decreased, due to the high intensity of the electrical stimulus, which is unacceptably painful in the unanesthetized or partially anesthetized patient. Therefore ancillary tests are needed which can detect spinal cord ischemia postoperatively early, thus preceding the phase with clinically overt paraparesis. The test should be reliable and easy to perform for an extended period of time (up to several days). The purpose of this study is to explore the usefulness of various neurophysiological tests regarding accuracy and feasibility for the detection of spinal cord ischemia. In particular, to find a diagnostic test which is acceptable for the unanesthetized or partially anesthetized patient and therefore can also be performed postoperatively. These tests will be examined in fully sedated as well as partially sedated patients. The following candidate tests will be examined: 1. Long loop reflexes (LLR) consisting of F-waves. 2. Oxygenation measurements of the paraspinal muscles using Near-infrared spectroscopy (NIRS).

NCT ID: NCT00583050 Completed - Clinical trials for Abdominal Aortic Aneurysm

Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts

Start date: February 2001
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the role of fenestrated/branched stent-grafts in the exclusion of abdominal aortic and thoracoabdominal aneurysms.